- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Evidence-Based Complementary and Alternative Medicine
Volume 2012 (2012), Article ID 195367, 12 pages
Chronic Administration of Oil Palm (Elaeis guineensis) Leaves Extract Attenuates Hyperglycaemic-Induced Oxidative Stress and Improves Renal Histopathology and Function in Experimental Diabetes
1Department of Pharmacology, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia
2School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800 Penang, Malaysia
3Department of Molecular Medicine, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia
4Department of Anatomy, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia
Received 6 August 2012; Accepted 17 October 2012
Academic Editor: Shrikant Anant
Copyright © 2012 Varatharajan Rajavel et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- C. E. Mogensen, C. K. Christensen, and E. Vittinghus, “The stages in diabetic renal disease. With emphasis on the stage of incipient diabetic nephropathy,” Diabetes, vol. 32, supplement 2, pp. 64–78, 1983.
- S. Dronavalli, I. Duka, and G. L. Bakris, “The pathogenesis of diabetic nephropathy,” Nature Clinical Practice Endocrinology and Metabolism, vol. 4, no. 8, pp. 444–452, 2008.
- H. Shamoon, H. Duffy, N. Fleischer et al., “The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus,” The New England Journal of Medicine, vol. 329, no. 14, pp. 977–986, 1993.
- R. Turner, “Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33),” The Lancet, vol. 352, no. 9131, pp. 837–853, 1998.
- Y. Ohkubo, H. Kishikawa, E. Araki et al., “Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study,” Diabetes Research and Clinical Practice, vol. 28, no. 2, pp. 103–117, 1995.
- T. H. Hostetter, “Hypertrophy and hyperfunction of the diabetic kidney,” The Journal of Clinical Investigation, vol. 107, no. 2, pp. 161–162, 2001.
- J. F. Navarro-González and C. Mora-Fernández, “The role of inflammatory cytokines in diabetic nephropathy,” Journal of the American Society of Nephrology, vol. 19, no. 3, pp. 433–442, 2008.
- T. Nishikawa, D. Edelstein, X. L. Du et al., “Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage,” Nature, vol. 404, no. 6779, pp. 787–790, 2000.
- M. Brownlee, “Biochemistry and molecular cell biology of diabetic complications,” Nature, vol. 414, no. 6865, pp. 813–820, 2001.
- F. Giacco and M. Brownlee, “Oxidative stress and diabetic complications,” Circulation Research, vol. 107, no. 9, pp. 1058–1070, 2010.
- J. M. Forbes, M. T. Coughlan, and M. E. Cooper, “Oxidative stress as a major culprit in kidney disease in diabetes,” Diabetes, vol. 57, no. 6, pp. 1446–1454, 2008.
- A. L. Eun, Y. S. Ji, Z. Jiang et al., “Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney,” Kidney International, vol. 67, no. 5, pp. 1762–1771, 2005.
- B. Halliwell, “Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment,” Drugs and Aging, vol. 18, no. 9, pp. 685–716, 2001.
- H. B. Lee, M. R. Yu, Y. Yang, Z. Jiang, and H. Ha, “Reactive oxygen species-regulated signaling pathways in diabetic nephropathy,” Journal of the American Society of Nephrology, vol. 14, no. 3, pp. S241–S245, 2003.
- Y. S. Kanwar, J. Wada, L. Sun et al., “Diabetic nephropathy: mechanisms of renal disease progression,” Experimental Biology and Medicine, vol. 233, no. 1, pp. 4–11, 2008.
- G. T. Mustata, M. Rosca, K. M. Biemel et al., “Paradoxical effects of green tea (Camellia sinensis) and antioxidant vitamins in diabetic rats: improved retinopathy and renal mitochondrial defects but deterioration of collagen matrix glycoxidation and cross-linking,” Diabetes, vol. 54, no. 2, pp. 517–526, 2005.
- J. F. E. Mann, E. M. Lonn, Q. Yi et al., “Effects of vitamin E on cardiovascular outcomes in people with mild-to-moderate renal insufficiency: results of the HOPE Study,” Kidney International, vol. 65, no. 4, pp. 1375–1380, 2004.
- A. Vignini, A. Alidori, L. Montesi et al., “Vitamin E, diabetes and related diseases: an update,” Mediterranean Journal of Nutrition and Metabolism, vol. 4, no. 1, pp. 3–9, 2011.
- J. M. Jaffri, S. Mohamed, N. Rohimi, I. N. Ahmad, M. M. Noordin, and Y. A. Manap, “Antihypertensive and cardiovascular effects of catechin-rich oil palm (Elaeis guineensis) leaf extract in nitric oxide-deficient rats,” Journal of Medicinal Food, vol. 14, no. 7-8, pp. 775–783, 2011.
- N. Khan and H. Mukhtar, “Tea polyphenols for health promotion,” Life Sciences, vol. 81, no. 7, pp. 519–533, 2007.
- R. T. Rosalina Tan, S. Mohamed, G. F. Samaneh, M. M. Noordin, Y. M. Goh, and M. Y. A. Manap, “Polyphenol rich oil palm leaves extract reduce hyperglycaemia and lipid oxidation in STZ-rats,” International Food Research Journal, vol. 18, no. 1, pp. 179–188, 2011.
- B. T. Doumas, D. D. Bayse, R. J. Carter, T. Peters Jr., and R. Schaffer, “A candidate Reference Method for determination of total protein in serum. I. Development and validation,” Clinical Chemistry, vol. 27, no. 10, pp. 1642–1650, 1981.
- M. Somogyi, “A method for the preparation of blood filtrates for the determination of sugar,” The Journal of Biological Chemistry, vol. 86, pp. 655–663, 1930.
- E. Bojesen, “A method for determination of inulin in plasma and urine,” Acta Medica Scandinavica. Supplementum, vol. 266, pp. 275–282, 1952.
- T. Saito, E. Sumithran, E. F. Glasgow, and R. C. Atkins, “The enhancement of aminonucleoside nephrosis by the co-administration of protamine,” Kidney International, vol. 32, no. 5, pp. 691–699, 1987.
- S. Taneda, J. W. Pippin, E. H. Sage et al., “Amelioration of diabetic nephropathy in SPARC-null mice,” Journal of the American Society of Nephrology, vol. 14, no. 4, pp. 968–980, 2003.
- I. Runnie, N. M. Mustapha, R. Musec et al., “Antioxidant and hypercholesterolemic effects of Elaies guineensis fond extract on hypercholesterolemic rats,” ASEAN Food Journal, no. 3, pp. 137–148, 2003.
- J. M. Jaffri, S. Mohamed, I. N. Ahmad, N. M. Mustapha, Y. A. Manap, and N. Rohimi, “Effects of catechin-rich oil palm leaf extract on normal and hypertensive rats' kidney and liver,” Food Chemistry, vol. 128, no. 2, pp. 433–441, 2011.
- T. H. Hostetter, J. L. Troy, and B. M. Brenner, “Glomerular hemodynamics in experimental diabetes mellitus,” Kidney International, vol. 19, no. 3, pp. 410–415, 1981.
- R. Veelken, K. F. Hilgers, A. Hartner, A. Haas, K. P. Böhmer, and R. B. Sterzel, “Nitric oxide synthase isoforms and glomerular hyperfiltration in early diabetic nephropathy,” Journal of the American Society of Nephrology, vol. 11, no. 1, pp. 71–79, 2000.
- R. Komers, T. J. Allen, and M. E. Cooper, “Role of endothelium-derived nitric oxide in the pathogenesis of the renal hemodynamic changes of experimental diabetes,” Diabetes, vol. 43, no. 10, pp. 1190–1197, 1994.
- R. Komers, J. N. Lindsley, T. T. Oyama et al., “Immunohistochemical and functional correlations of renal cyclooxygenase-2 in experimental diabetes,” The Journal of Clinical Investigation, vol. 107, no. 7, pp. 889–898, 2001.
- J. Li, Y. J. Chen, and J. Quilley, “Effect of tempol on renal cyclooxygenase expression and activity in experimental diabetes in the rat,” Journal of Pharmacology and Experimental Therapeutics, vol. 314, no. 2, pp. 818–824, 2005.
- Y. J. Chen, J. Li, and J. Quilley, “Effect of inhibition of nitric oxide synthase on renal cyclooxygenase in the diabetic rat,” European Journal of Pharmacology, vol. 541, no. 1-2, pp. 80–86, 2006.
- D. Koya, I. K. Lee, H. Ishii, H. Kanoh, and G. L. King, “Prevention of glomerullar dysfunction in diabetic rats by treatment with d--tocopherol,” Journal of the American Society of Nephrology, vol. 8, no. 3, pp. 426–435, 1997.
- M. F. Melhem, P. A. Craven, and F. R. DeRubertis, “Effects of dietary supplementation of α-Lipoic acid on early glomerular injury in diabetes mellitus,” Journal of the American Society of Nephrology, vol. 12, no. 1, pp. 124–133, 2001.
- J. Su, P. Zhang, J. J. Zhang, X. M. Qi, Y. G. Wu, and J. J. Shen, “Effects of total glucosides of paeony on oxidative stress in the kidney from diabetic rats,” Phytomedicine, vol. 17, no. 3-4, pp. 254–260, 2010.
- M. Satoh, S. Fujimoto, Y. Haruna et al., “NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy,” American Journal of Physiology, vol. 288, no. 6, pp. F1144–F1152, 2005.
- K. Susztak, A. C. Raff, M. Schiffer, and E. P. Böttinger, “Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy,” Diabetes, vol. 55, no. 1, pp. 225–233, 2006.
- N. Kashihara, Y. Watanabe, H. Makino, E. I. Wallner, and Y. S. Kanwar, “Selective decreased de novo synthesis of glomerular proteoglycans under the influence of reactive oxygen species,” Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 14, pp. 6309–6313, 1992.
- H. Vink and B. R. Duling, “Identification of distinct luminal domains for macromolecules, erythrocytes, and leukocytes within mammalian capillaries,” Circulation Research, vol. 79, no. 3, pp. 581–589, 1996.
- F. R. DeRubertis, P. A. Craven, M. F. Melhem, and E. M. Salah, “Attenuation of renal injury in db/db mice overexpressing superoxide dismutase: evidence for reduced superoxide—nitric oxide interaction,” Diabetes, vol. 53, no. 3, pp. 762–768, 2004.
- R. F. Spurney and T. M. Coffman, “Stressed-out podocytes in diabetes?” Journal of the American Society of Nephrology, vol. 19, no. 11, pp. 2035–2037, 2008.
- S. Zheng, E. C. Carlson, L. Yang, P. M. Kralik, Y. Huang, and P. N. Epstein, “Podocyte-specific overexpression of the antioxidant metallothionein reduces diabetic nephropathy,” Journal of the American Society of Nephrology, vol. 19, no. 11, pp. 2077–2085, 2008.
- N. Yamabe, T. Yokozawa, T. Oya, and M. Kim, “Therapeutic potential of (-)-epigallocatechin 3-O-gallate on renal damage in diabetic nephropathy model rats,” Journal of Pharmacology and Experimental Therapeutics, vol. 319, no. 1, pp. 228–236, 2006.
- F. Bhatti, R. W. Mankhey, L. Asico, M. T. Quinn, W. J. Welch, and C. Maric, “Mechanisms of antioxidant and pro-oxidant effects of α-lipoic acid in the diabetic and nondiabetic kidney,” Kidney International, vol. 67, no. 4, pp. 1371–1380, 2005.
- H. A. H. Kataya and A. A. Hamza, “Red cabbage (Brassica oleracea) ameliorates diabetic nephropathy in rats,” Evidence-Based Complementary and Alternative Medicine, vol. 5, no. 3, pp. 281–287, 2008.
- R. M. Mason and N. A. Wahab, “Extracellular matrix metabolism in diabetic nephropathy,” Journal of the American Society of Nephrology, vol. 14, no. 5, pp. 1358–1373, 2003.
- P. A. Craven, F. R. Derubertis, V. E. Kagan, M. Melhem, and R. K. Studer, “Effects of supplementation with vitamin C or E on albuminuria, glomerular TGF-β, and glomerular size in diabetes,” Journal of the American Society of Nephrology, vol. 8, no. 9, pp. 1405–1414, 1997.
- H. Ha and Hi Bahl Lee, “Reactive oxygen species as glucose signaling molecules in mesangial cells cultured under high glucose,” Kidney International, Supplement, vol. 58, no. 77, pp. S19–S25, 2000.
- M. C. Iglesias-De La Cruz, P. Ruiz-Torres, J. Alcamí et al., “Hydrogen peroxide increases extracellular matrix mRNA through TGF-β in human mesangial cells,” Kidney International, vol. 59, no. 1, pp. 87–95, 2001.
- R. K. Studer, P. A. Craven, and F. R. DeRubertis, “Antioxidant inhibition of protein kinase C-signaled increases in transforming growth factor-beta in mesangial cells,” Metabolism, vol. 46, no. 8, pp. 918–925, 1997.
- H. Ha, S. H. Lee, and K. H. Kim, “Effects of rebamipide in a model of experimental diabetes and on the synthesis of transforming growth factor-β and fibronectin, and lipid peroxidation induced by high glucose in cultured mesangial cells,” Journal of Pharmacology and Experimental Therapeutics, vol. 281, no. 3, pp. 1457–1462, 1997.
- E. B. M. I. Peixoto, B. S. Pessoa, S. K. Biswas, and J. B. Lopes De Faria, “Antioxidant SOD mimetic prevents NADPH oxidase-induced oxidative stress and renal damage in the early stage of experimental diabetes and hypertension,” American Journal of Nephrology, vol. 29, no. 4, pp. 309–318, 2009.
- H. Li, F. Wang, L. Zhang et al., “Modulation of Nrf2 expression alters high glucose-induced oxidative stress and antioxidant gene expression in mouse mesangial cells,” Cellular Signalling, vol. 23, no. 10, pp. 1625–1632, 2011.
- H. Ha and K. H. Kim, “Pathogenesis of diabetic nephropathy: the role of oxidative stress and protein kinase C,” Diabetes Research and Clinical Practice, vol. 45, no. 2-3, pp. 147–151, 1999.
- I. G. Obrosova, L. Fathallah, E. Liu, and J. Nourooz-Zadeh, “Early oxidative stress in the diabetic kidney: effect of DL-α-lipoic acid,” Free Radical Biology and Medicine, vol. 34, no. 2, pp. 186–195, 2003.
- K. I. Sugimoto, S. Tsuruoka, and A. Fujimura, “Effect of enalapril on diabetic nephropathy in OLETF rats: the role of an anti-oxidative action in its protective properties,” Clinical and Experimental Pharmacology and Physiology, vol. 28, no. 10, pp. 826–830, 2001.
- P. S. Van Dam, B. Bravenboer, B. S. Van Asbeck, J. F. L. M. Van Oirschot, J. J. M. Marx, and W. H. Gispen, “Effects of insulin treatment on endoneurial and systemic oxidative stress in relation to nerve conduction in streptozotocin-diabetic rats,” European The Journal of Clinical Investigation, vol. 26, no. 12, pp. 1143–1149, 1996.
- M. Kakimoto, T. Inoguchi, T. Sonta et al., “Accumulation of 8-hydroxy-2′-deoxyguanosine and mitochondrial DNA deletion in kidney of diabetic rats,” Diabetes, vol. 51, no. 5, pp. 1588–1595, 2002.